• Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl

  2026-06-25

  This study elucidates how Polo-like kinase 1 (Plk1) directly regulates the activity of p31comet through phosphorylation, modulating the disassembly of mitotic checkpoint complexes. These findings clarify a critical control mechanism ensuring proper chromosome segregation, with implications for cell cycle research and potential translational applications.

• 2',7'-Dichlorofluorescein Diacetate Probe for Reliable ROS D

  2026-06-25

  2',7'-Dichlorofluorescein diacetate empowers high-sensitivity intracellular ROS measurement, enabling robust oxidative stress assays in translational cancer research, drug discovery, and toxicology. This guide delivers actionable workflow enhancements and troubleshooting strategies, leveraging innovations from nanocarrier-enabled pancreatic cancer studies and validated best practices for reproducibility.

• Redefining mRNA Delivery: Dual-Fluorescent Reporters for Tra

  2026-06-24

  This thought-leadership article explores how advanced, immune-evasive, dual-fluorescence mRNA reporters—exemplified by EZ Cap™ Cy5 EGFP mRNA (5-moUTP)—are reshaping experimental design and translational workflows in gene delivery research. By blending mechanistic insight with strategic guidance, it addresses the evolving demands of precise delivery, quantitative tracking, and immune response mitigation, drawing on recent evidence and cross-disciplinary innovation to illuminate new frontiers for translational scientists.

• Annexin V-APC/7-AAD Apoptosis Kit: Precision Cell Death Dete

  2026-06-23

  The Annexin V-APC/7-AAD Apoptosis Kit empowers researchers with rapid, high-sensitivity detection of apoptosis and necrosis in diverse experimental systems. Its streamlined one-step protocol and dual-fluorophore design set a new standard for quantitative, reproducible cell death analysis in cancer, immunology, and beyond.

• Polyphosphazene Nanoparticles: Protein Delivery and Crosslin

  2026-06-23

  This study demonstrates how ionic polyphosphazene polymers, crosslinked with spermine tetrahydrochloride, enable the formation of nanoparticulate and soluble protein delivery systems with tunable properties. The work provides new comparative data on protein stability, bioactivity, and cellular presentation, informing both materials science and biomedical applications.

• Mitoxantrone HCl Disrupts ERα via DBD-LBD Interface Targetin

  2026-06-22

  Wang et al. identify a novel allosteric inhibition mechanism for estrogen receptor alpha (ERα) in breast cancer by targeting the interface between its DNA- and ligand-binding domains with mitoxantrone, a DNA topoisomerase II inhibitor. This approach induces rapid proteasomal degradation of both wild-type and therapy-resistant ERα, highlighting a promising strategy to overcome endocrine resistance.

• BFH772 (VEGFR2 inhibitor): Technical Use and Workflow Guidan

  2026-06-22

  BFH772 is a potent, selective VEGFR2 inhibitor designed for research applications requiring precise modulation of VEGFR2-driven angiogenesis, particularly in tumor angiogenesis studies. It is not suitable for workflows requiring water solubility or broad-spectrum kinase inhibition due to its defined selectivity and solubility profile.

• Angiotensin II-HIF-1α-HILPDA Axis Drives Radioresistance in

  2026-06-21

  This study reveals how local angiotensin II suppresses ferroptosis and promotes radioresistance in nasopharyngeal carcinoma (NPC) through the HIF-1α-HILPDA axis. The findings identify actionable molecular targets for sensitizing NPC to radiotherapy and guide future strategies for overcoming resistance.

• Cy3-dCTP: Precision Fluorescent Labeling in DNA Synthesis

  2026-06-20

  Cyanine 3-dCTP empowers direct, high-yield DNA and cDNA fluorescent labeling, streamlining workflows from PCR to in situ hybridization. With robust polymerase compatibility and protocol flexibility, APExBIO’s Cy3-dCTP sets a new benchmark for reproducible probe generation and multiplexed detection.

• Temafloxacin: Fluoroquinolone Broad-Spectrum Antibacterial P

  2026-06-19

  Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent with potent in vitro and in vivo activity against both Gram-positive and Gram-negative pathogens. Its primary mechanism is inhibition of bacterial DNA gyrase and topoisomerase IV, with documented efficacy in respiratory and intracellular infection models. Its benchmarked MICs and protocol parameters support its use in research on antibiotic resistance and advanced antibacterial assays.

• 3D Shell MEAs Enable High-Resolution Mapping in Cardiac Orga

  2026-06-19

  This study introduces programmable shell microelectrode arrays (MEAs) that achieve comprehensive, high-resolution 3D electrophysiological mapping in cardiac organoids. The platform enables detailed analysis of spatiotemporal field potentials and pharmacological responses, advancing functional cardiac disease modeling and proarrhythmic substrate research.

• AZD6482: Precision PI3Kβ Inhibitor for Metabolic and Platele

  2026-06-18

  AZD6482 stands out as a highly selective PI3Kβ inhibitor, enabling nuanced dissection of the PI3K/Akt/mTOR pathway in disease modeling and translational research. Its robust selectivity and well-characterized pharmacology make it ideal for probing metabolic regulation and anti-thrombotic mechanisms in vitro and in vivo.

• X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside): Prec

  2026-06-18

  Explore the advanced use of X-Gal in blue-white colony screening and β-galactosidase assays. This article uniquely connects chromogenic substrate selection to sensory gene regulation, offering protocol clarity and a new translational perspective.

• NVP-BGJ398 Phosphate: Optimizing FGFR Inhibition in Research

  2026-06-17

  NVP-BGJ398 phosphate is redefining FGFR-targeted research, enabling precise modulation of FGFR1/2/3 signaling in both cancer and skeletal disease models. This article details experimental workflows, troubleshooting strategies, and translational insights from the latest reference study, empowering researchers to unlock its full potential.

• SM-164: Deep Mechanistic Insights for Translational Apoptosi

  2026-06-17

  Explore SM-164, a potent bivalent Smac mimetic, with a unique focus on integrating mechanistic depth and translational assay design. This article delivers advanced guidance on apoptosis induction in tumor cells, distinguishing itself from prior content by emphasizing practical, evidence-driven decisions for cancer research.

444 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page